article thumbnail

Low-dose Doxycycline Curbs Symptoms of Lymphocytic Scarring Alopecia, Minus the Side Effects of Higher Doses

The Dermatology Digest

Small amounts of doxycycline can curb symptoms of lymphocytic scarring alopecia, a new study shows. The new study is the first to directly compare the efficacy of different-size doses of doxycycline to treat lymphocytic scarring alopecia, says Needle. As a result, the team set out to determine whether lower doses could work instead.

article thumbnail

Dr. Speron's Natural Scar Removal Cream Recognized as Best New Skincare Product in 2023 by Skin and Beauty Journal

MedEsthetics

The natural cream uses a combination of active ingredients specifically designed to target scar tissue and help restore the skin’s natural look and feel.

article thumbnail

Divots, Depressed Scars, & Other Concavities

Skin Tour

Scars will often need multiple modalities to treat them like lasers, subcision and radiofrequency. Remember, there is a type of basal cell skin cancer that can look like a depressed scar and develops slowly over time. The post Divots, Depressed Scars, & Other Concavities appeared first on Skintour.

article thumbnail

Quercetin vs Hydroxychloroquine: What's the Difference? (2023)

Aesthetics Advisor

As of December 2023, there are more than 3,000 studies published related to the treatment and prevention of COVID-19. As of December 2023, there have been more than 10 published studies of quercetin against COVID-19. As of November 2023, there are more than 350 published evidence of hydroxychloroquine for COVID-19 ( c19hcq.org ).

article thumbnail

Can Topical Retinoids Decrease Atrophic Scars?

Dermatology Times

Linda Stein Gold, MD, reviewed recent studies of various topical retinoids and their ability to decrease atrophic scars during the 2023 ARM Yourself With Knowledge webinar.

article thumbnail

One to Watch: DenovoSkin Shows Promise in Reconstructive Surgery, Burns

The Dermatology Digest

It aims to significantly reduce the need for healthy skin harvesting, significantly reduce scarring, as well as reduce the need for follow-up corrective surgeries. “We Following the announced positive primary endpoint in Q1 2023, the one-year readout evaluated long term safety and scar quality. Stay tuned.

Surgery 73
article thumbnail

Hydroxychloroquine vs Ivermectin vs Quercetin: What's the Difference? (2023 Edition)

Aesthetics Advisor

As of August 2023, there are more than 3,000 studies published related to the treatment and prevention of COVID-19. As of August 2023, there are more than 90 studies on ivermectin and COVID-19. As of August 2023, there are more than 350 published evidence of hydroxychloroquine for COVID-19 ( c19hcq.org ).